Stents, scaffolds and DCB

This session presents a comprehensive exploration of vascular interventions, highlighting advanced techniques such as retrograde tibial artery approaches for long CTO lesions in the superficial femoral artery, catheter-directed thrombectomy for bilateral pulmonary embolism, and innovative endovascular management of pulmonary haemorrhages in Eisenmenger syndrome. Case reports and...

This session offers an in-depth review of the SELUTION DeNovo study, highlighting its implications for PCI practice. It covers the innovative technology of the SELUTION drug-eluting balloon and practical integration strategies through expert case discussions.

Guillaume Bonnet interviews Christian Spaulding about the SELUTION DeNovo Trial he presented at TCT 2025, in San Francisco. 

Prof. Christian Spaulding, principal investigator of the study, discusses the trial design, key outcomes, breaks down the nuances behind the sirolimus DCB strategy versus contemporary DES, and shares insights...

This individual patient data analysis of the three largest RCTs evaluating IVUS-guided stent optimisation showed that an MSA > 5.5 mm2 was associated with reduced TVF at one year. 

Alessandro Sticchi provides us with a curated overview of the late-breaking trials he found most relevant for interventional cardiologists from AHA 2025.

The PCR Trials Book provides updates on the latest randomised clinical trials of relevance to practicing interventional cardiologists in the field of coronary, valvular and structural interventions. Each trial, selected by the Editors, has been synthesised in order to provide you with a concise overview. View a...

The SELUTION DeNovo trial, presented by Christian Spaulding at TCT 2025, delivers the first head-to-head comparison between a sirolimus DCB strategy and contemporary DES in PCI.

In this review, Salvatore Brugaletta breaks down the 1-year results and what these findings truly mean for everyday lesion-by-lesion decision-making.

Ali Nazmi Calik provides his take on the OCVC-BIF study presented by Takayuki Ishihara at TCT 2025, in San Francisco.

Alex Sticchi interviews Lei Song on the IRONMAN II trial he presented at TCT 2025, in San Francisco.

Watch this replay with F. Ribichini, M. Götberg, B. Khialani and B. Vaquerizo to Review the newest indications for the use of DCB with a focus on STEMI, CTO, bifurcations and calcified lesions, and so much more!